Vijay Bhargava, Ph.D., is Corporate EVP and Global Head of Drug Metabolism and Pharmacokinetics and NIBR (Novartis Institutes for Biomedical Research) East Hanover Site Head
Q: Novartis Pharmaceuticals Corporation (NPC) has had a remarkable diversity journey in the past few years. How do you feel that’s changed the culture of the company
